Evidence map›Paper›PMID 38650939›Full record

ArticleFrontiers in immunology2024

Poly I:C elicits broader and stronger humoral and cellular responses to a

Tiffany B L Costa-Gouvea, Katia S Françoso, Rodolfo F Marques, Alba Marina Gimenez, Ana C M Faria, Leonardo M Cariste, Mariana R Dominguez, José Ronnie C Vasconcelos, Helder I Nakaya, Eduardo L V Silveira and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Tiffany B L Costa-GouveaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Katia S FrançosoDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Rodolfo F MarquesDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Alba Marina GimenezDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Ana C M FariaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Leonardo M CaristeLaboratório de Vacinas Recombinantes, Departamento de Biociências, Universidade Federal de São Paulo, Santos, Brazil.
Mariana R DominguezDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
José Ronnie C VasconcelosLaboratório de Vacinas Recombinantes, Departamento de Biociências, Universidade Federal de São Paulo, Santos, Brazil.
Helder I NakayaDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Eduardo L V SilveiraDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Irene S SoaresDepartment of Clinical and Toxicological Analyses, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, Brazil.
Universidade de São Paulo · BRFleury S.A. (Brazil) · BRUniversidade Federal de São Paulo · BRUniversidade Metropolitana de Santos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malaria remains a global health challenge, necessitating the development of effective vaccines. The RTS,S vaccination prevents

Indexed as

Adjuvants, VaccineAluminum HydroxideImmunogenicity, VaccineMalaria VaccinesMalaria, VivaxPlasmodium vivaxPoly I-CProtozoan ProteinsAnimalsFemaleImmunity, CellularImmunity, HumoralImmunoglobulin GMaleMice, Inbred C57BLPlasma CellsAdjuvants, VaccineAluminum Hydroxidecircumsporozoite protein, ProtozoanImmunoglobulin GMalaria VaccinesPoly I-CProtozoan ProteinsRecombinant Proteinsadjuvantantibody-secreting cellsmalariamemory B cellsTLR3-ligand

Identifiers

PMID38650939
PMCPMC11033515
OpenAlexW4394575542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.